12 February 2012 - 2:44 pm NZ time
Listen live or
listen again here
Updated at 10:42 am on 3 July 2009
Johnson & Johnson is buying a stake in an Irish company developing drugs to treat Alzheimer's disease.
The healthcare group is to pay $US1 billion for 18.4% of Elan Corp plc. It will buy rights to most of the company's portfolio of experimental drugs.
Shares in Elan rose 8.6% on Thursday to close at $US7.60 on the New York Stock Exchange. J&J's share price fell 1.9% to $US55.98.
Copyright © 2009, Radio New Zealand
Audio is categorised based on the frequency of the programme it was heard in. Click on the headings below to access the programmes. If you are unsure where to look, try the latest audio page.
Streams are in Windows Media format. Mac and Linux users see our help section.
If you use Windows Vista and streaming has stopped working see our help section.
Downloads and Podcasts are available on selected programmes. Our podcast page has a complete list of feeds.